Fourth Theranostics World Congress - Save the Date

4twc

Ga 700 Banner

 

The 3rd Theranostics World Congress (3TWC) took place on the campus of Johns Hopkins University on March 12-14, 2015.

We received over 100 abstracts for the World Congress.  Thank You!

This activity has been approved for AMA PRA Category 1 Credits

The Congress, Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and Johns Hopkins Medicine, is intended for chemists, physicists, technologists, physicians and all scientists and clinicians interested in translational research and current state-of-the-art molecular imaging using 68Ga PET radiopharmaceuticals and radionuclide therapy. The increase in enthusiasm for 68Ga use over the last several years can be ascribed to several factors, some of which promise an increasing role for 68Ga as a tool in both diagnostic and therapeutic applications such as theranostics. The term "theranostics" symbolizes the inseparability of diagnosis and therapy and has a profound effect personalized disease management. Click here to download the Congress Flyer.

 Although widely used in Europe, 68Ga PET radiopharmaceuticals have only been used in the US in investigational trials under INDs. With the potential of an approved agent available in the US in the near future, this conference is particularly useful to those who are new to this class of agent and want to hear more about it. A team of experts from around the world present their research and discuss updates in this exciting and evolving field. Presentations on clinical applications and patient advocacy are new to this Congress, providing a unique perspective for attendees.

Agenda Outline.

Thursday, March 12, 2015
Generators, Post-Processing, and Synthesis Modules
Chelators and Labeling Chemistry for Theranostic Isotopes
Theranostic Targeting Vectors

Friday, March 13, 2015
Peptide Receptor Radiotherapy – Status Quo and Where to Go
Targeting Prostate Cancer: Imaging and Therapy
Established and Innovative Applications for Diagnosis and Therapy

Saturday, March 14, 2015
State of the Art Management of NETs – Clinician and Patient Perspectives
Imaging with Gallium – From D to T (Diagnosis to Therapy)
How to Deliver Theranostics

Program Committee
Richard Wahl (USA), Co-Chair Richard Baum (Germany), Co-Chair
Horacio Amaral (Chile) Thomas O'Dorisio (USA)
Michael Graham (USA) Frank Roesch (Germany)
Peter Herscovitch (USA) Mike Sathekge (South Africa)
Michael Hofman (Australia) Michael Schultz (USA)
Ulrich Keller (Germany) Baljinder Singh (India)
Michael Lassmann (Germany) Ronald Walker (USA)
Helmut Mäcke (Germany) Wolfgang Weber (USA)
Corina Millo (USA)

 


Please join our mailing list so that we can update you as soon as we have more information.

If you are interested in sponsoring or exhibiting at the 3TWC, please see our sponsorship section.